Meeting
2016 ASCO Annual Meeting
Comparison of oncometabolite 2-hydroxyglutarate (2HG) levels in mutant isocitrate dehydrogenase (IDH) versus wild-type (WT) glioma tissues.
Authors
Hao-Wen Sim
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Hao-Wen Sim , Gelareh Zadeh , Warren P. Mason , Ken Aldape , Mark Bernstein , Fred Gentili , Mojgan Hodaie , Suneil Kalia , Paul N. Kongkham , Wenjiang Zhang , Takyee Tung , Eric Xueyu Chen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2028)
DOI
10.1200/JCO.2016.34.15_suppl.2028
Abstract #
2028
Poster Bd #
217
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas.
First Author: Michael DeCuypere
Poster
2017 ASCO Annual Meeting
Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
First Author: Aline P. Becker
Poster
2023 ASCO Annual Meeting
Intra-operative desorption-electrospray ionization mass-spectrometry for real-time diagnosis, margin assessment, and maximization of brain cancer resection.
First Author: Diogo Garcia
Poster
2022 ASCO Annual Meeting
A single-institution, retrospective examination of new contrast enhancement, progression, and pseudoprogression in IDH mutant glioma.
First Author: Ethan Wetzel